| Primary |
| Niemann-pick Disease |
57.9% |
| Gaucher's Disease |
24.9% |
| Tay-sachs Disease |
4.0% |
| Product Used For Unknown Indication |
3.8% |
| Lipidosis |
2.1% |
| Glycogen Storage Disease Type Ii |
1.4% |
| Convulsion |
0.9% |
| Depression |
0.7% |
| Vitamin Supplementation |
0.7% |
| Cataplexy |
0.5% |
| Epilepsy |
0.5% |
| Interferon Gamma Receptor Deficiency |
0.5% |
| Leukodystrophy |
0.5% |
| Accidental Exposure |
0.2% |
| Agitation |
0.2% |
| Dementia |
0.2% |
| Electroneurography |
0.2% |
| Insomnia |
0.2% |
| Platelet Count Increased |
0.2% |
| Vitamin D Deficiency |
0.2% |
|
| Weight Decreased |
25.4% |
| Death |
10.4% |
| Tremor |
9.5% |
| Niemann-pick Disease |
8.0% |
| Convulsion |
7.0% |
| Diarrhoea |
5.0% |
| Pneumonia |
4.5% |
| Thrombocytopenia |
4.0% |
| Disease Progression |
2.5% |
| Epilepsy |
2.5% |
| Growth Retardation |
2.5% |
| Pneumonia Aspiration |
2.5% |
| Pyrexia |
2.5% |
| Respiratory Failure |
2.5% |
| Vomiting |
2.5% |
| Dysphagia |
2.0% |
| Renal Failure |
2.0% |
| Walking Disability |
2.0% |
| Alanine Aminotransferase Increased |
1.5% |
| Bone Pain |
1.5% |
|
| Secondary |
| Niemann-pick Disease |
69.7% |
| Gaucher's Disease |
15.4% |
| Depression |
3.9% |
| Vitamin Supplementation |
3.9% |
| Glycogen Storage Disease Type Ii |
1.3% |
| Lipidosis |
1.3% |
| Platelet Count Increased |
1.3% |
| Epilepsy |
0.9% |
| Tay-sachs Disease |
0.9% |
| Vitamin D Deficiency |
0.9% |
| Off Label Use |
0.4% |
|
| Weight Decreased |
27.7% |
| Tremor |
8.0% |
| Diarrhoea |
5.8% |
| Vomiting |
5.8% |
| Walking Disability |
5.8% |
| Renal Failure |
4.4% |
| Thrombocytopenia |
4.4% |
| Asthenia |
3.6% |
| Ear Haemorrhage |
3.6% |
| Factor X Deficiency |
3.6% |
| General Physical Health Deterioration |
3.6% |
| Growth Retardation |
3.6% |
| Anxiety |
2.9% |
| Osteopenia |
2.9% |
| Somnolence |
2.9% |
| Drug Ineffective |
2.2% |
| Hepatic Neoplasm Malignant |
2.2% |
| Mood Altered |
2.2% |
| Pain |
2.2% |
| Platelet Count Decreased |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.7% |
| Gaucher's Disease |
29.3% |
| Supplementation Therapy |
13.3% |
| Hypothyroidism |
5.3% |
| Spinal Pain |
5.3% |
| Asthma |
4.0% |
| Diuretic Therapy |
2.7% |
| Dyspepsia |
2.7% |
| Epilepsy |
2.7% |
| Contraception |
1.3% |
| Dystonia |
1.3% |
| Pulmonary Thrombosis |
1.3% |
|
| Fatigue |
13.3% |
| Menorrhagia |
13.3% |
| Upper Respiratory Tract Infection |
13.3% |
| Urine Output Decreased |
13.3% |
| B-cell Lymphoma |
6.7% |
| Lymphoma |
6.7% |
| Prothrombin Time Ratio Decreased |
6.7% |
| Pulmonary Thrombosis |
6.7% |
| Pyrexia |
6.7% |
| Respiratory Disorder |
6.7% |
| Weight Increased |
6.7% |
|
